Literature DB >> 25181506

[Retinal Arterial Macroaneurysms (RAM)--pathology, differenzial diagnoses, and therapy].

S Bopp1, A M Joussen2.   

Abstract

Retinal arterial macroaneurysms (RAM) are unilateral, solitary, acquired saccular or fusiform dilatations of the large arterioles of the retina, usually within the first three orders of bifurcation. They are associated with systemic vascular conditions such as hypertension and arteriosclerotic disease and occur most commonly in elderly women. Cases of simple RAM are predominated by the vascular ectasia. These macroaneurysms regress without treatment and without causing decreased visual acuity and will usually remain undetected. Complex RAM often go along with vision loss due to haemorrhage or oedema affecting the macula. Poor visual outcome may occur secondary to foveal exudates and subfoveal haemorrhage, the latter appear as pre-retinal, intra-, and subretinal haemorrhage. This overview discusses conservative and surgical therapeutic options for complex cases. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25181506     DOI: 10.1055/s-0034-1382953

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  [Laser membranotomy in the management of acute premacular hemorrhage : Case report and overview on the approach].

Authors:  M Roth; L Eisenkopf; D Engineer; J C Schmidt
Journal:  Ophthalmologe       Date:  2018-12       Impact factor: 1.059

2.  Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms.

Authors:  Caroline Bormann; Jens Heichel; Ute Hammer; Anke Habermann; Thomas Hammer
Journal:  Case Rep Ophthalmol       Date:  2017-03-07

3.  Optical coherence tomography (OCT) angiography findings in retinal arterial macroaneurysms.

Authors:  Maged Alnawaiseh; Friederike Schubert; Pieter Nelis; Gabriele Wirths; André Rosentreter; Nicole Eter
Journal:  BMC Ophthalmol       Date:  2016-07-22       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.